SALT OF THIENO[2,3-D]IMIDAZOLE COMPOUND, CRYSTAL FORM THEREOF AND PHARMACEUTICAL USE THEREOF

Title:

SALT OF THIENO[2,3-D]IMIDAZOLE COMPOUND, CRYSTAL FORM THEREOF AND PHARMACEUTICAL USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/246839

Kind Code:

A1

Abstract:

The present invention provides a salt of a compound with GLP-1R agonist activity, as represented by formula (I), and/or a crystal form, and preparation and pharmaceutical use, wherein a pharmaceutically acceptable salt is selected from a tris(hydroxymethyl)aminomethane salt or a triethanolamine salt:

More Like This:

JP7366194	Organometallic compound and organic electroluminescent device containing the same
JP2005523925	Heterocyclic compounds for pesticides
JP4326855	Thiol compounds, their production methods and their intermediates

Inventors:

GONG ZHENG (CN)
ZHU FENGFEI (CN)
FAN JIANG (CN)
LIU ZHENPING (CN)
DOU YING (CN)

Application Number:

PCT/CN2023/101590

Publication Date:

December 28, 2023

Filing Date:

June 21, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TIBET HAISCO PHARMACEUTICAL CO LTD (CN)

International Classes:

C07D495/04; A61K31/497; A61P3/10; C07D401/04; C07D405/14; C07D413/14; C07D513/04

Domestic Patent References:

WO2021244645A1	2021-12-09
WO2021249492A1	2021-12-16
WO2022135572A1	2022-06-30

Foreign References:

CN113853371A	2021-12-28
CN114591296A	2022-06-07

Attorney, Agent or Firm:

BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: DISEASE MODEL AND USE THEREOF

Next Patent: COMBINATION OF IL-12 AND OX40L FOR CANCER IMMUNOTHERAPY